×




Novo Nordisk (B): The Prandin/Novonorm Global Product Launch Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Novo Nordisk (B): The Prandin/Novonorm Global Product Launch case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Novo Nordisk (B): The Prandin/Novonorm Global Product Launch case study is a Harvard Business School (HBR) case study written by Joel Podolny, John Roberts, Aldo Kemper. The Novo Nordisk (B): The Prandin/Novonorm Global Product Launch (referred as “Prandin Novonorm” from here on) case study provides evaluation & decision scenario in field of Global Business. It also touches upon business topics such as - Value proposition, International business.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Novo Nordisk (B): The Prandin/Novonorm Global Product Launch Case Study


The FDA believed that Prandin was a very innovative drug that would provide the fast-growing number of Americans suffering from type II diabetes with a better and more convenient treatment for their health problems. For this reason, the FDA was willing to put Prandin application on the fast track which would allow Novo Nordisk to have the product registered (thus making it legal to sell) in a maximum of 6 months. The decision to schedule the initial worldwide launch of Prandin/Novonorm in the United States in an extremely short time frame was not easy at all.


Case Authors : Joel Podolny, John Roberts, Aldo Kemper

Topic : Global Business

Related Areas : International business




Calculating Net Present Value (NPV) at 6% for Novo Nordisk (B): The Prandin/Novonorm Global Product Launch Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10000536) -10000536 - -
Year 1 3457152 -6543384 3457152 0.9434 3261464
Year 2 3967119 -2576265 7424271 0.89 3530722
Year 3 3940333 1364068 11364604 0.8396 3308380
Year 4 3236375 4600443 14600979 0.7921 2563512
TOTAL 14600979 12664078




The Net Present Value at 6% discount rate is 2663542

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Internal Rate of Return
2. Net Present Value
3. Profitability Index
4. Payback Period

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Prandin Novonorm shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Prandin Novonorm have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of Novo Nordisk (B): The Prandin/Novonorm Global Product Launch

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Global Business Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Prandin Novonorm often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Prandin Novonorm needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10000536) -10000536 - -
Year 1 3457152 -6543384 3457152 0.8696 3006219
Year 2 3967119 -2576265 7424271 0.7561 2999712
Year 3 3940333 1364068 11364604 0.6575 2590833
Year 4 3236375 4600443 14600979 0.5718 1850408
TOTAL 10447172


The Net NPV after 4 years is 446636

(10447172 - 10000536 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10000536) -10000536 - -
Year 1 3457152 -6543384 3457152 0.8333 2880960
Year 2 3967119 -2576265 7424271 0.6944 2754944
Year 3 3940333 1364068 11364604 0.5787 2280285
Year 4 3236375 4600443 14600979 0.4823 1560752
TOTAL 9476941


The Net NPV after 4 years is -523595

At 20% discount rate the NPV is negative (9476941 - 10000536 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Prandin Novonorm to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Prandin Novonorm has a NPV value higher than Zero then finance managers at Prandin Novonorm can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Prandin Novonorm, then the stock price of the Prandin Novonorm should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Prandin Novonorm should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Understanding of risks involved in the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What can impact the cash flow of the project.

What will be a multi year spillover effect of various taxation regulations.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Novo Nordisk (B): The Prandin/Novonorm Global Product Launch

References & Further Readings

Joel Podolny, John Roberts, Aldo Kemper (2018), "Novo Nordisk (B): The Prandin/Novonorm Global Product Launch Harvard Business Review Case Study. Published by HBR Publications.


Analyst IMS SWOT Analysis / TOWS Matrix

Financial , Investment Services


Lafang China SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Personal & Household Prods.


Xiamen R&T Plumbing SWOT Analysis / TOWS Matrix

Capital Goods , Constr. - Supplies & Fixtures


Level Brands SWOT Analysis / TOWS Matrix

Services , Business Services


Fletcher King SWOT Analysis / TOWS Matrix

Services , Real Estate Operations


Seihyo SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Christie SWOT Analysis / TOWS Matrix

Services , Business Services


Cosmoam&T SWOT Analysis / TOWS Matrix

Technology , Office Equipment


WooGene B&G SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Shanghai Highly A SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods


Grana y Montero SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services